As always it's an honor to be a co-author with some very terrific researchers and this paper is a good one. We are releasing one of the subset results of SWOG clinical trial S1216. This subset is on circulating tumor cells (CTC) and their prognostic/predictive value. This is the largest cohort of hormonally sensitive metastatic patients. This data will be well received at ASCO this year. Here is the link to my site with more information on trial S1216:
advancedpcatalk.freeforums.net/thread/263/s1216-update-subset-promising-biomarker